Suchergebnisse - "Drew, Yvette"

PubPharm (64)

31

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors

enthalten in: Clinical pharmacology in drug development | 2019

von Shapiro, G. | Kristeleit, R. | Burris, H. | +9

32

Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors

enthalten in: Clinical Pharmacology in Drug Development | 2019

von Shapiro, G. | Kristeleit, R. | Burris, H. | +9

33

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor

enthalten in: Cancer medicine | 2018

von Franklin, M. | Gentles, L. | Matheson, E. | +10

34

Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase

enthalten in: Blood advances | 2018

von Fordham, S. | Blair, H. | Elstob, C. | +15

35

A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Kristeleit, R. | Shapiro, G. | Burris, H. | +17

36

Targeting the ATR-CHK1 Axis in Cancer Therapy

enthalten in: Cancers | 2017

von Rundle, S. | Bradbury, A. | Drew, Y. | +1

37

Emerging treatment options for ovarian cancer : focus on rucaparib

enthalten in: International journal of women's health | 2017

von Mariappan, L. | Jiang, X. | Jackson, J. | +1

38

A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Jamieson, D. | Griffin, M. | Sludden, J. | +19

39

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

enthalten in: British journal of cancer | 2016

von Drew, Y. | Ledermann, J. | Hall, G. | +14

ErratumFor: Br J Cancer. 2016 Mar 29;114(7):723-30. - PMID 27002934

40

Homologous recombination deficiency and ovarian cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Ledermann, J. | Drew, Y. | Kristeleit, R.